Cite
HARVARD Citation
Shibuya, T. et al. (2018). Alteration of serum thymus and activation‐regulated chemokine level during biologic therapy for psoriasis: Possibility as a marker reflecting favorable response to anti‐interleukin‐17A agents. Journal of dermatology. 45 (6), pp. 710-714. [Online].